Delphi-consensus weights for ischemic and bleeding events to be included in a composite outcome for RCTs in thrombosis prevention

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Dechartres, Agnes ^a,b,c   Albaladejo, Pierre ^d,e   Mantz, Jean ^b,f   Samama, Charles Marc ^b,c   Collet, Jean Philippe ^g,h   Steg, Philippe Gabriel ^a,b,i   Ravaud, Philippe ^a,b,c   Tubach, Florence ^a,b,i  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔTEL DIEU   (France)

^d GRENOBLE UNIVERSITY HOSPITAL   (France)

^e UNIV GRENOBLE ALPES   (France)

^f BEAUJON HOSPITAL   (France)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^h SORBONNE UNIVERSITÉ   (France)

ⁱ BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CONSENSUS DEVELOPMENT; DELPHI STUDY; DISABILITY; DISEASE SEVERITY; HUMAN; LUNG EMBOLISM; MEDICAL SPECIALIST; OUTCOME ASSESSMENT; POPLITEAL VEIN; PROFESSIONAL KNOWLEDGE; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RATING SCALE; THROMBOSIS PREVENTION; VEIN THROMBOSIS; BLEEDING; ISCHEMIA; STROKE; THROMBOSIS; TREATMENT OUTCOME;

ACETYLSALICYLIC ACID;

ASPIRIN; HEMORRHAGE; HUMANS; ISCHEMIA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STROKE; THROMBOSIS; TREATMENT OUTCOME;

EID: 79954566287     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018461     Document Type: Article

References (27)

1. Cordoba G, Schwartz L, Woloshin S, Bae H, Gotzsche PC, (2010) Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review. BMJ 341: c3920.
2. Ferreira-Gonzalez I, Permanyer-Miralda G, Busse JW, Bryant DM, Montori VM, et al. (2007) Methodologic discussions for using and interpreting composite endpoints are limited, but still identify major concerns. J Clin Epidemiol 60: 651-657; discussion 658-662.
3. Lim E, Brown A, Helmy A, Mussa S, Altman DG, (2008) Composite outcomes in cardiovascular research: a survey of randomized trials. Ann Intern Med 149: 612-617.
4. Ferreira-Gonzalez I, Busse JW, Heels-Ansdell D, Montori VM, Akl EA, et al. (2007) Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials. BMJ 334: 786.
5. Freemantle N, Calvert M, Wood J, Eastaugh J, Griffin C, (2003) Composite outcomes in randomized trials: greater precision but with greater uncertainty? JAMA 289: 2554-2559.
6. Freemantle N, Calvert MJ, (2010) Interpreting composite outcomes in trials. BMJ 341: c3529.
7. Ross S, (2007) Composite outcomes in randomized clinical trials: arguments for and against. Am J Obstet Gynecol 196: 119 e111-116.
8. Pogue J, Thabane L, Devereaux PJ, Yusuf S, (2010) Testing for heterogeneity among the components of a binary composite outcome in a clinical trial. BMC Med Res Methodol 10: 49.
9. Tugwell P, Judd MG, Fries JF, Singh G, Wells GA, (2005) Powering our way to the elusive side effect: a composite outcome 'basket' of predefined designated endpoints in each organ system should be included in all controlled trials. J Clin Epidemiol 58: 785-790.
10. Ferreira-Gonzalez I, Permanyer-Miralda G, Busse JW, Devereaux PJ, Guyatt GH, et al. (2009) Composite outcomes can distort the nature and magnitude of treatment benefits in clinical trials. Ann Intern Med 150: 566-567.
11. Montori VM, Permanyer-Miralda G, Ferreira-Gonzalez I, Busse JW, Pacheco-Huergo V, et al. (2005) Validity of composite end points in clinical trials. BMJ 330: 594-596.
12. Neaton JD, Gray G, Zuckerman BD, Konstam MA, (2005) Key issues in end point selection for heart failure trials: composite end points. J Card Fail 11: 567-575.
13. Braunwald E, Cannon CP, McCabe CH, (1992) An approach to evaluating thrombolytic therapy in acute myocardial infarction. The 'unsatisfactory outcome' end point. Circulation 86: 683-687.
14. Sampson UK, Metcalfe C, Pfeffer MA, Solomon SD, Zou KH, (2010) Composite outcomes: weighting component events according to severity assisted interpretation but reduced statistical power. J Clin Epidemiol 63: 1156-1158.
15. Califf RM, Harrelson-Woodlief L, Topol EJ, (1990) Left ventricular ejection fraction may not be useful as an end point of thrombolytic therapy comparative trials. Circulation 82: 1847-1853.
16. Dalkey NC, Helmer O, (1963) An experimental application of the Delphi method to the use of experts. Manage Sci.
17. Delbecq AL, van de Ven AH, Gustafson DH, (1975) Group techniques for program planning; a guide to nominal group and Delphi processes. Glenview Scott, Foresman.
18. Dalkey NC, (1969) The delphi method: an experimental study of group opinion. Santa Monica, CA RAND Corporation.
19. Fink A, Kosecoff J, Chassin M, Brook RH, (1984) Consensus methods: characteristics and guidelines for use. Am J Public Health 74: 979-983.
20. Pill J, (1971) The Delphi method: substance, context, a critique and an annotated bibliography. Socio-Econ Plan Sci 5: 57-71.
21. Program CTE (2006) Common Terminology Criteria for Adverse Events, Version 3.0, DCTD, NCI, NIH, DHHS. March 31, 2003 (http://ctep.cancer.gov).
22. Bland JM, Altman DG, (1997) Cronbach's alpha. BMJ 314: 572.
23. Bravo G, Potvin L, (1991) Estimating the reliability of continuous measures with Cronbach's alpha or the intraclass correlation coefficient: toward the integration of two traditions. J Clin Epidemiol 44: 381-390.
24. R Development Core Team (2009) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria ISBN 3-900051-07-0, URL http://www.r-project.org/.
25. Kraemer HC, Frank E, (2010) Evaluation of comparative treatment trials: assessing clinical benefits and risks for patients, rather than statistical effects on measures. JAMA 304: 683-684.
26. Felker GM, Anstrom KJ, Rogers JG, (2008) A global ranking approach to end points in trials of mechanical circulatory support devices. J Card Fail 14: 368-372.
27. Rahimi K, Malhotra A, Banning AP, Jenkinson C, (2010) Outcome selection and role of patient reported outcomes in contemporary cardiovascular trials: systematic review. BMJ 341: c5707.